Carlos Rogelio Alvizo Rodríguez

Dr. Carlos Rogelio Alvizo Rodríguez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in Molecules
Verified
Journal Article
Open access
PDF file
CRCarlos Rogelio Alvizo Rodríguez
Carlos Rogelio Alvizo Rodríguez
Fernando CalzadaFernando Calzada
Fernando Calzada
UVUriel López Vázquez
Uriel López Vázquez
ETEmmanuel Tomay
Emmanuel Tomay
JHJuan Alex Hernández-Rivera
Juan Alex Hernández-Rivera
MHMarta Elena Hernandez-Caballero
Marta Elena Hernandez-Caballero
Kalanchoe pinnata is used in traditional medicine to treat cancer, as it contains flavonoids and phenols known to regulate key cellular processes associated with cancer. Breast cancer, the most common cancer among women globally, presents ongoing challenges in treatment. The discovery of m6A methylation and its regulation by methylosome proteins offers novel therapeutic avenues for cancer management. This study aimed to investigate the cytotoxic and epitranscriptomic effects of an aqueous extract from K. pinnata on MCF-7 (luminal A) and HCC1937 (triple-negative) breast cancer cells. Cell lines were treated with the aqueous K. pinnata extract, characterized by HPLC, for 72 h, followed by an assessment of cytotoxicity and migration. The expression of methylosome components METTL3 and FTO was measured using RT-PCR. m6A global methylation was assessed via colorimetry, and molecular docking studies were conducted. The results indicated that only HCC1937 cells exhibited altered migration capacity. This change was correlated in silico with the inhibition of METTL3 by luteolin and quercetin, constituents of the aqueous extract. METTL3, a methyltransferase, was overexpressed by scratch stimuli but was downregulated following K. pinnata treatment in both MCF-7 and HCC1937 cells. The FTO demethylase was overexpressed in both cell lines. In silico analysis suggested an interaction between FTO and compounds such as gallic acid and myricetin. Additionally, m6A global methylation decreased in MCF-7 cells but increased in HCC1937 cells, potentially affecting cell migration. Our findings indicate that K. pinnata influences both METTL3 and FTO, altering m6A methylation in a cell-type-dependent manner, with HCC1937 cells being particularly sensitive. Further research is required to elucidate the complete molecular mechanism of K. pinnata’s aqueous extract in breast cancer treatment.

1 June 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
CRCarlos Rogelio Alvizo Rodríguez
Carlos Rogelio Alvizo Rodríguez
Maria de la Luz Ayala-MadrigalMaria de la Luz Ayala-Madrigal
Maria de la Luz Ayala-Madrigal
BFBeatriz Armida Flores-Lopez
Beatriz Armida Flores-Lopez
MPMiriam Partida-Pérez
Miriam Partida-Pérez
NMNelly Margarita Macías-Gómez
Nelly Margarita Macías-Gómez
Melva Gutierrez-AnguloMelva Gutierrez-Angulo
Melva Gutierrez-Angulo
Background: Colorectal cancer is the second cause of death by cancer around the world. Sporadic colorectal cancer is the most frequent (75%), and it is produced by the interaction of environmental, epigenetic, and genetic factors. The accumulation of single-nucleotide variants in genes associated with cell proliferation, DNA repair, and/or apoptosis could confer a risk to cancer. The aim of this study was to analyze the gene–gene interactions among CCND2 (rs3217901), CDKN1A (rs1059234 and rs1801270), and POLD3 (rs3824999) vari- ants in Mexican patients with colorectal cancer. Methods: We collected peripheral blood samples from 185 patients with sporadic colorectal cancer before treatment and from 185 unre- lated blood donors as the reference group; all participants signed an informed consent form. DNA extraction was performed by Miller and Cetyltrimethylammonium bromide (CTAB)/ Dodecyltrimethylammonium bromide (DTAB) methods. Polymerase chain reaction– restriction fragment length polymorphism followed by polyacrylamide gel electrophoresis stained with AgNO3 methods were used to identify the variants rs3217901, rs1059234, rs1801270, and rs3824999. Odds ratio and single-nucleotide variant interaction were determined by single-locus analysis and Multifactorial Dimensionality Reduction software, respectively. Results: No association was found for CCND2 and CDKN1A variants; yet, a significant association for the GG genotype, G allele, and recessive and additive models for the POLD3 variant was observed (P < .05). The single-nucleotide variant–single-nucleotide vari- ant interaction revealed the combination rs1059234, rs3217901, and rs3824999 as the best model and the comparison showed an increased risk (P < .05). Conclusion: Single-locus and gene–gene interaction analyses disclosed that both the rs3824999 (POLD3) variant and the combination of rs3217901 (CCND2), rs1059234 (CDKN1A), and rs3824999 (POLD3) genotypes increase the risk for colorectal cancer in Mexican population.

9 July 2025 in ACS Omega
Verified
Journal Article
Open access
CRCarlos Rogelio Alvizo Rodríguez
Carlos Rogelio Alvizo Rodríguez
ACAlan Carrasco-Carballo
Alan Carrasco-Carballo
ULUriel López-Vázquez
Uriel López-Vázquez
GHGeorgina Hernández-Montes
Georgina Hernández-Montes
MHMarta Elena Hernandez-Caballero
Marta Elena Hernandez-Caballero
Triple-negative breast cancer (TNBC) is a type of breast cancer with high mortality due to aggressive tumor behavior and limited treatment options. Natural products have been studied for their potential as alternatives to combine with cancer drugs to improve treatment efficacy. Plant phytoconstituents can regulate cellular processes such as proliferation, differentiation, invasion, angiogenesis, and migration. Kalanchoe pinnata has been used in traditional medicine; it contains flavonoids, phenols, alkaloids, glycosides, bufadienolides, and tannins, among others. In the present investigation, we evaluated the effects of aqueous extract and the underlying molecular mechanisms in two breast cancer cell lines, HCC1937 and MDA-MB-231, with a focus on cellular migration. The cytotoxic activity results revealed that HCC1937 cells are more sensitive to aqueous extracts than are MDA-MB-231 cells. Compared with that of 48 h-treated MDA-MB-231 cells, cell migration was affected in HCC1937 cells after 24 h of treatment. The extract had greater anti-invasion effects on HCC1937 cells (37.7%, p < 0.01) than on MDA-MB-231 cells (47%, p < 0.05). An RNA-seq assay revealed 1850 differentially expressed genes (DEGs) in HCC1937 cells versus 1534 in MDA-MB-231 cells. WebGestalt analysis revealed the downregulation of genes involved in cell–cell adhesion, ruffle organization, and cell–substrate junctions, with more downregulated genes in HCC1937 cells. The downregulated genes analyzed with KOBAS-i were associated with MAPK signaling, focal adhesion, PI3K-Akt signaling, regulation of the actin cytoskeleton, and the ECM-receptor interaction pathway. In addition, IPA network analysis revealed that the RHO GTPase cycle, RHOA signaling, JAK/STAT signaling, actin cytoskeleton signaling and Integrin signaling pathways were inhibited. The data from the docking study indicated the binding potential of quercetin-3-O-arabinoside, kaempferol, quercetin, and apigenin with the JAK2, ROCK1, ROCK2, and PIK3CA proteins. Thus, our results demonstrate that K. pinnata inhibits the proliferation and invasion of TNBC cells by targeting genes involved in these important processes; thus, K. pinnata has the potential to be used in combination with chemotherapeutic drugs for cancer treatment.

25 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
JVJosé Luis Venegas-Rodríguez
José Luis Venegas-Rodríguez
JHJesús Arturo Hernández
Jesús Arturo Hernández
Melva Gutierrez-AnguloMelva Gutierrez-Angulo
Melva Gutierrez-Angulo
JOJOSE MIGUEL MORENO ORTIZ
JOSE MIGUEL MORENO ORTIZ
AMAnahí González Mercado
Anahí González Mercado
Maria de la Luz Ayala-MadrigalMaria de la Luz Ayala-Madrigal
Maria de la Luz Ayala-Madrigal
We searched for the prevalence of actionable somatic mutations in exon 2 of the KRAS gene in western Mexican patients with CRC. Tumor tissue DNA samples from 150 patients with sporadic CRC recruited at the Civil Hospital of Guadalajara were analyzed. Mutations in exon 2 of the KRAS gene were identified using Sanger sequencing, and the data were analyzed considering clinical–pathological characteristics. Variants in codon 12 (rs121913529 G>A, G>C, and G>T) and codon 13 (rs112445441 G>A) were detected in 26 patients (with a prevalence of 17%). No significant associations were found between these variants and clinical–pathological characteristics (p > 0.05). Furthermore, a comprehensive search was carried out in PubMed/NCBI and Google for the prevalence of KRAS exon 2 mutations in Latin American populations. The 17 studies included 12,604 CRC patients, with an overall prevalence of 30% (95% CI = 0.26–0.35), although the prevalence ranged from 13 to 43% across the different data sources. Determining the variation and frequency of KRAS alleles in CRC patients will enhance their potential to receive targeted treatments and contribute to the understanding of the genomic profile of CRC.

7 July 2026 in ACS Omega
Verified
Journal Article
Open access
RVRicardo Villalobos-Valencia
Ricardo Villalobos-Valencia
CRCarlos Rogelio Alvizo Rodríguez
Carlos Rogelio Alvizo Rodríguez
ACAlan Carrasco-Carballo
Alan Carrasco-Carballo
JSJosé A. Sierra-Ramírez
José A. Sierra-Ramírez
ULUriel López-Vázquez
Uriel López-Vázquez
MHMarta Elena Hernandez-Caballero
Marta Elena Hernandez-Caballero